These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Italian multicenter study on the treatment of chronic obstructive lung disease with bromhexine. A double-blind placebo-controlled trial. Valenti S; Marenco G Respiration; 1989; 56(1-2):11-5. PubMed ID: 2690235 [TBL] [Abstract][Full Text] [Related]
43. [Vectarian international multicenter study (VIMS) in hypoxemic chronic bronchitis patients treated by the double-blind placebo method for 1 year. Follow-up of the monitoring of 490 patients]. Ansquer JC Rev Med Interne; 1985; 6 Spec No():31-7. PubMed ID: 3914682 [No Abstract] [Full Text] [Related]
44. Double-blind clinical trial of domiodol vs S-carboxymethylcysteine in chronic obstructive lung disease. Casali L; Rampulla C; Rossi A Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):554-7. PubMed ID: 6757153 [TBL] [Abstract][Full Text] [Related]
45. Aerosolized detergents and mucolytic agents in the treatment of stable chronic obstructive pulmonary disease. Barton AD Am Rev Respir Dis; 1974 Dec; 110(6 Pt 2):104-10. PubMed ID: 4613216 [No Abstract] [Full Text] [Related]
46. Effects of corticosteroid use on readmission in obstructive lung disease. Velthove KJ; Souverein PC; van Solinge WW; Leufkens HG; Lammers JW Respir Med; 2010 Feb; 104(2):211-8. PubMed ID: 19781925 [TBL] [Abstract][Full Text] [Related]
47. Morbidity of survivors of neonatal respiratory distress syndrome under four years of age. Yang PH Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1996; 37(2):103-6. PubMed ID: 8935407 [TBL] [Abstract][Full Text] [Related]
48. Bronchitis among the British. Reid DD Isr J Med Sci; 1971 Dec; 7(12):1569-72. PubMed ID: 5144600 [No Abstract] [Full Text] [Related]
49. Effect of 30 mg of morphine alone or with promethazine or prochlorperazine on the exercise capacity of patients with COPD. Light RW; Stansbury DW; Webster JS Chest; 1996 Apr; 109(4):975-81. PubMed ID: 8635380 [TBL] [Abstract][Full Text] [Related]
50. Comparison of oral salbutamol and ephedrine in chronic obstructive pulmonary disease. Kamat SR; Hoskote VR; Store SD; Sanghavi B; Sheth UK Indian J Chest Dis Allied Sci; 1978 Apr; 20(2):54-62. PubMed ID: 363609 [No Abstract] [Full Text] [Related]
51. Lung function studies in epidemiologic investigations of respiratory diseases. Ulmer WT Bull Physiopathol Respir (Nancy); 1970; 6(3):605-16. PubMed ID: 5522011 [No Abstract] [Full Text] [Related]
52. [Respiratory insufficiency in chronic obstruction lung diseases. Etiology, age, sex and color. I]. Lisboa RM; da Silveira IC; Malogolowkin I; Osiek S Rev Bras Med; 1971 Sep; 28(9):451-5. PubMed ID: 5139638 [No Abstract] [Full Text] [Related]
53. [Diribiotine aerosols administered to patients with chronic bronchial obstruction. Double-blind study]. Obrecht U; Scherrer M Rev Med Suisse Romande; 1975 May; 95(5):345-59. PubMed ID: 1101345 [No Abstract] [Full Text] [Related]
54. Double blind study of hydroxyzine, promethazine, secobarbital, and a placebo for preanaesthetic medication. Dobkin AB; Malik K; Israel JS Can Anaesth Soc J; 1965 Sep; 12(5):499-509. PubMed ID: 5324001 [No Abstract] [Full Text] [Related]
55. [Epidemiological study of chronic obstructive bronchopneumopathy in a district of the city of Bucharest]. Duţu S; Bungeţianu G; Jienescu Z Ftiziologia; 1972; 21(3):261-82. PubMed ID: 4664385 [No Abstract] [Full Text] [Related]
57. Respiratory symptoms and obstructive pulmonary disease in a population aged over 70 years. Hardie JA; Vollmer WM; Buist AS; Bakke P; Mørkve O Respir Med; 2005 Feb; 99(2):186-95. PubMed ID: 15715185 [TBL] [Abstract][Full Text] [Related]
58. A 3-year cohort study on short-term effects of air pollution in Germany. 1. Influences of medication and season. Franke K; Boeriu A; Degens P; Dresler R; Fritsch H; Haake D; Hahn M; Hanisch E; Hempel A; Höltmann B Sci Total Environ; 1992 Dec; 127(1-2):69-78. PubMed ID: 1480959 [TBL] [Abstract][Full Text] [Related]
59. [Occupational exposure to harmful substances and its significance in the development of chronic obstructive lung diseases]. Rebohle E Z Erkr Atmungsorgane; 1983; 161(3):266-72. PubMed ID: 6670316 [TBL] [Abstract][Full Text] [Related]
60. Tucson epidemiologic study of obstructive lung diseases. II: Effects of in-migration factors on the prevalence of obstructive lung diseases. Lebowitz MD; Burrows B Am J Epidemiol; 1975 Aug; 102(2):153-63. PubMed ID: 1155444 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]